Evidence map›Paper›PMID 27511009›Full record

ArticleThe Journal of neuroscience : the official journal of the Society for Neuroscience2016

Amyloid Precursor Protein Protects Neuronal Network Function after Hypoxia via Control of Voltage-Gated Calcium Channels.

Dimitri Hefter, Martin Kaiser, Sascha W Weyer, Ismini E Papageorgiou, Martin Both, Oliver Kann, Ulrike C Müller, Andreas Draguhn

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of neuroscience : the official journal of the Society for Neuroscience, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
3.7field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 41 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Review
  5. APPsα Rescues Tau-Induced Synaptic Pathology.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2022
    Article
  6. CaInternational journal of molecular sciences · 2022
    Review
  7. APPsα rescues impaired CaProceedings of the National Academy of Sciences of the United States of America · 2021
    Article
  8. Review
  9. Amyloid, APP, and Electrical Activity of the Brain.The Neuroscientist : a review journal bringing neurobiology, neurology and psychiatry · 2020
    Review
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. TheThe Journal of biological chemistry · 2019
    Article
  16. Alzheimer's disease: pathogenesis, diagnostics, and therapeutics.International journal of nanomedicine · 2019
    Review
  17. DistinctThe EMBO journal · 2018
    Article
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 2 countries.

Dimitri HefterInstitute of Physiology and Pathophysiology and.
Martin KaiserInstitute of Physiology and Pathophysiology and.
Sascha W WeyerInstitute of Pharmacy and Molecular Biotechnology, Department of Bioinformatics and Functional Genomics, University of Heidelberg, D-69210 Heidelberg, Germany.
Ismini E PapageorgiouInstitute of Physiology and Pathophysiology and.
Martin BothInstitute of Physiology and Pathophysiology and.ORCID 0000-0003-1847-9796
Oliver KannInstitute of Physiology and Pathophysiology and.
Ulrike C MüllerInstitute of Pharmacy and Molecular Biotechnology, Department of Bioinformatics and Functional Genomics, University of Heidelberg, D-69210 Heidelberg, Germany.
Andreas DraguhnInstitute of Physiology and Pathophysiology and andreas.draguhn@physiologie.uniheidelberg.de.ORCID 0000-0002-6243-5582
Czech Academy of Sciences, Institute of Physiology · CZHeidelberg University · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

unlabelledAcute cerebral ischemia and chronic neurovascular diseases share various common mechanisms with neurodegenerative diseases, such as disturbed cellular calcium and energy homeostasis and accumulation of toxic metabolites. A link between these conditions may be constituted by amyloid precursor protein (APP), which plays a pivotal role in the pathogenesis of Alzheimer's disease, but has also been associated with the response to acute hypoxia and regulation of calcium homeostasis. We therefore studied hypoxia-induced loss of function and recovery upon reoxygenation in hippocampal slices of mice lacking APP (APP(-/-)) or selectively expressing its soluble extracellular domain (APPsα-KI). Transient hypoxia disrupted electrical activity at the network and cellular level. In mice lacking APP, these impairments were significantly more severe, showing increased rise of intracellular calcium, faster loss of function, and higher incidence of spreading depression. Likewise, functional recovery upon reoxygenation was much slower and less complete than in controls. Most of these deficits were rescued by selective expression of the soluble extracellular fragment APPsα, or by pharmacological block of L-type calcium channels. We conclude that APP supports neuronal resistance toward acute hypoxia. This effect is mediated by the secreted APPsα-domain and involves L-type calcium channels. SIGNIFICANCE STATEMENT: Amyloid precursor protein (APP) is involved in the pathophysiology of Alzheimer's disease, but its normal function in the brain remains elusive. Here, we describe a neuroprotective role of the protein in acute hypoxia. Functional recovery of mouse hippocampal networks after transient reduction of oxygen supply was strongly impaired in animals lacking APP. Most protective effects are mediated by the soluble extracellular fragment APPsα and involve L-type calcium channels. Thus, APP contributes to calcium homeostasis in situations of metabolic stress. This finding may shed light on the physiological function of APP and may be important for understanding mechanisms of neurodegenerative diseases.

Indexed as

3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl esterAmyloid beta-PeptidesAmyloid beta-Protein PrecursorAnimalsCalcium Channel AgonistsCalcium Channel BlockersCalcium Channels, L-TypeEvoked PotentialsExcitatory Postsynaptic PotentialsFemaleHippocampusHypoxiaMaleMiceMice, Inbred C57BLMice, Transgenic3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl esterAmyloid beta-PeptidesAmyloid beta-Protein PrecursorCalcium Channel AgonistsCalcium Channel BlockersCalcium Channels, L-TypeNifedipineAPPhippocampushypoxiaL-type calcium channelsneuroprotectionnifedipine

Identifiers

PMID27511009
PMCPMC6601858
OpenAlexW2488287378

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.